Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 PM
Ignite Modification Date:
2025-12-24 @ 11:55 PM
NCT ID:
NCT06540651
Eligibility Criteria:
Inclusion Criteria:
* Male or female, of 18 years years old or more;
* Diagnosis of chronic cluster headache according to ICHD-3 criteria;
* Number of seizures during baseline equal to at least 24;
* Stability of prophylactic treatment for at least 1 month and commitment not to change it for the duration of the study;
* Patient affiliated to the French social security system.
* Patient who understands and speaks French correctly;
* Patient who has given free and informed written consent.
Exclusion Criteria:
* Contraindication to the use of light therapy: use of a photosensitizing treatment;
* Ophthalmological history: cataract, macular degeneration, glaucoma, retinitis pigmentosa;
* Patients who work at night;
* Other neurological, psychiatric or developmental pathologies considered incompatible with the study;
* Background treatment of cluster headache with melatonin;
* Persons protected by articles L1121-5, L1121-6 and L1121-8 of the French Public Health Code (pregnant or breast-feeding women, persons deprived of their liberty by judicial decision, socially vulnerable persons, adults incapable or unable to express their consent).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06540651
Study Brief:
Protocol Section:
NCT06540651